Literature DB >> 26668690

Long noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanism.

Yong-Ru Liu1, Rui-Xue Tang1, Wen-Ting Huang1, Fang-Hui Ren1, Rong-Quan He1, Li-Hua Yang1, Dian-Zhong Luo1, Yi-Wu Dang1, Gang Chen1.   

Abstract

Hepatocellular carcinoma (HCC) is the predominant subject of liver malignancies which arouse global concern. Advanced studies have found that long noncoding RNAs (lncRNAs) are differentially expressed in HCC and implicate they may play distinct roles in the pathogenesis and metastasis of HCC. However, the underlying mechanisms remain largely unclear. In this review, we summarized the functions and mechanisms of those known aberrantly expressed lncRNAs identified in human HCC tissues. We hope to enlighten more comprehensive researches on the detailed mechanisms of lncRNAs and their application in clinic, such as being used as diagnostic and prognostic biomarkers and the targets for potential therapy. Although studies on lncRNAs in HCC are still deficient, an improved understanding of the roles played by lncRNAs in HCC will lead to a much more effective utilization of those lncRNAs as novel candidates in early detection, diagnosis, prevention and treatment of HCC.

Entities:  

Keywords:  Dysregulation; Hepatocellular carcinoma; Long noncoding RNA; Mechanism; Pathway

Year:  2015        PMID: 26668690      PMCID: PMC4670950          DOI: 10.4254/wjh.v7.i28.2781

Source DB:  PubMed          Journal:  World J Hepatol


  115 in total

1.  A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression.

Authors:  Delphine Bernard; Kannanganattu V Prasanth; Vidisha Tripathi; Sabrina Colasse; Tetsuya Nakamura; Zhenyu Xuan; Michael Q Zhang; Frédéric Sedel; Laurent Jourdren; Fanny Coulpier; Antoine Triller; David L Spector; Alain Bessis
Journal:  EMBO J       Date:  2010-08-20       Impact factor: 11.598

2.  ZAK inhibits human lung cancer cell growth via ERK and JNK activation in an AP-1-dependent manner.

Authors:  Jaw-Ji Yang; Yi-Ju Lee; Hsin-Hung Hung; Wei-Pu Tseng; Chuan-Chou Tu; Huei Lee; Wen-Jun Wu
Journal:  Cancer Sci       Date:  2010-02-18       Impact factor: 6.716

3.  A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma.

Authors:  Ji-hang Yuan; Fu Yang; Fang Wang; Jin-zhao Ma; Ying-jun Guo; Qi-fei Tao; Feng Liu; Wei Pan; Tian-tian Wang; Chuan-chuan Zhou; Shao-bing Wang; Yu-zhao Wang; Yuan Yang; Ning Yang; Wei-ping Zhou; Guang-shun Yang; Shu-han Sun
Journal:  Cancer Cell       Date:  2014-04-24       Impact factor: 31.743

4.  Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation.

Authors:  Ming-chun Lai; Zhe Yang; Lin Zhou; Qian-qian Zhu; Hai-yang Xie; Feng Zhang; Li-ming Wu; Lei-ming Chen; Shu-sen Zheng
Journal:  Med Oncol       Date:  2011-06-16       Impact factor: 3.064

5.  The HOX gene network in hepatocellular carcinoma.

Authors:  Clemente Cillo; Giulia Schiavo; Monica Cantile; Michel P Bihl; Paolo Sorrentino; Vincenza Carafa; Maria D' Armiento; Massimo Roncalli; Sebastiano Sansano; Raffaela Vecchione; Luigi Tornillo; Lucia Mori; Gennaro De Libero; Jessica Zucman-Rossi; Luigi Terracciano
Journal:  Int J Cancer       Date:  2011-05-30       Impact factor: 7.396

6.  The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.

Authors:  Lu-Nan Qi; Tao Bai; Zu-Shun Chen; Fei-Xiang Wu; Yuan-Yuan Chen; Bang- De Xiang; Tao Peng; Ze-Guang Han; Le-Qun Li
Journal:  Liver Int       Date:  2014-01-27       Impact factor: 5.828

7.  A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population.

Authors:  Yao Liu; Shandong Pan; Li Liu; Xiangjun Zhai; Jibin Liu; Juan Wen; Yixin Zhang; Jianguo Chen; Hongbing Shen; Zhibin Hu
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

8.  Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge.

Authors:  Liang Deng; Shi-Bin Yang; Feng-Feng Xu; Ji-Hong Zhang
Journal:  J Exp Clin Cancer Res       Date:  2015-02-19

9.  Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma.

Authors:  Hui Xie; Hongwei Ma; Danqiu Zhou
Journal:  Biomed Res Int       Date:  2013-05-22       Impact factor: 3.411

10.  Long non-coding RNA HOTAIR promotes cell migration and invasion via down-regulation of RNA binding motif protein 38 in hepatocellular carcinoma cells.

Authors:  Chaofeng Ding; Shaobing Cheng; Zhe Yang; Zhen Lv; Heng Xiao; Chengli Du; Chuanhui Peng; Haiyang Xie; Lin Zhou; Jian Wu; Shusen Zheng
Journal:  Int J Mol Sci       Date:  2014-03-06       Impact factor: 5.923

View more
  21 in total

Review 1.  Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review).

Authors:  Patrick Reichl; Wolfgang Mikulits
Journal:  Oncol Rep       Date:  2016-06-01       Impact factor: 3.906

2.  Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects.

Authors:  Zhangang Xiao; Jing Shen; Lin Zhang; Mingxing Li; Wei Hu; Chihin Cho
Journal:  Oncol Lett       Date:  2018-01-09       Impact factor: 2.967

3.  Identification of Circulating Long Noncoding RNA HOTAIR as a Novel Biomarker for Diagnosis and Monitoring of Non-Small Cell Lung Cancer.

Authors:  Nandi Li; Yingchao Wang; Xuefang Liu; Ping Luo; Wei Jing; Man Zhu; Jiancheng Tu
Journal:  Technol Cancer Res Treat       Date:  2017-08-08

4.  LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma.

Authors:  Jiangfeng Hu; Chenlin Song; Bensong Duan; Xiaoyan Zhang; Dongliang Li; Liang Zhu; Hengjun Gao
Journal:  Oncotarget       Date:  2017-05-29

5.  Hepatocellular Carcinoma: a Comprehensive Review ofzzm321990Biomarkers, Clinical Aspects, and Therapy

Authors:  Nathalia Martines Tunissiolli; Márcia Maria Urbanin Castanhole-Nunes; Patrícia Matos Biselli-Chicote; Érika Cristina Pavarino; Renato Ferreira da Silva; Rita de Cássia Martins Alves da Silva; Eny Maria Goloni-Bertollo
Journal:  Asian Pac J Cancer Prev       Date:  2017-04-01

6.  A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.

Authors:  Wen Ni; Yuqin Zhang; Zetao Zhan; Feng Ye; Yonghao Liang; Jing Huang; Keli Chen; Longhua Chen; Yi Ding
Journal:  J Hematol Oncol       Date:  2017-04-19       Impact factor: 17.388

7.  Lymphocyte-specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation.

Authors:  Hongyong Zhang; Yufeng Wang; Zhikui Liu; Bowen Yao; Changwei Dou; Meng Xu; Qing Li; Yuli Jia; Shengli Wu; Kangsheng Tu; Qingguang Liu
Journal:  FEBS Open Bio       Date:  2016-11-07       Impact factor: 2.693

8.  Microarray analysis of long non-coding RNA expression profiles in monocytic myeloid-derived suppressor cells in Echinococcus granulosus-infected mice.

Authors:  Aiping Yu; Ying Wang; Jianhai Yin; Jing Zhang; Shengkui Cao; Jianping Cao; Yujuan Shen
Journal:  Parasit Vectors       Date:  2018-05-30       Impact factor: 3.876

Review 9.  The biology of Hepatocellular carcinoma: implications for genomic and immune therapies.

Authors:  Galina Khemlina; Sadakatsu Ikeda; Razelle Kurzrock
Journal:  Mol Cancer       Date:  2017-08-30       Impact factor: 27.401

10.  Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.

Authors:  Dong-Yue Wen; Peng Lin; Yu-Yan Pang; Gang Chen; Yun He; Yi-Wu Dang; Hong Yang
Journal:  Med Sci Monit       Date:  2018-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.